JP2011518857A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518857A5 JP2011518857A5 JP2011506688A JP2011506688A JP2011518857A5 JP 2011518857 A5 JP2011518857 A5 JP 2011518857A5 JP 2011506688 A JP2011506688 A JP 2011506688A JP 2011506688 A JP2011506688 A JP 2011506688A JP 2011518857 A5 JP2011518857 A5 JP 2011518857A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- functional fragment
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12588008P | 2008-04-29 | 2008-04-29 | |
| US61/125,880 | 2008-04-29 | ||
| PCT/EP2009/055129 WO2009133103A1 (en) | 2008-04-29 | 2009-04-28 | Inhibitors of gm-csf and il-17 for therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011518857A JP2011518857A (ja) | 2011-06-30 |
| JP2011518857A5 true JP2011518857A5 (https=) | 2012-05-24 |
| JP5771140B2 JP5771140B2 (ja) | 2015-08-26 |
Family
ID=40810025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011506688A Active JP5771140B2 (ja) | 2008-04-29 | 2009-04-28 | 治療用のｇｍ−ｃｓｆおよびｉｌ−１７阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9353180B2 (https=) |
| EP (1) | EP2279001B1 (https=) |
| JP (1) | JP5771140B2 (https=) |
| KR (2) | KR20160117643A (https=) |
| CN (2) | CN102014958A (https=) |
| AU (1) | AU2009242088B2 (https=) |
| BR (1) | BRPI0911469A8 (https=) |
| CA (1) | CA2717987C (https=) |
| EA (1) | EA024654B1 (https=) |
| ES (1) | ES2557494T3 (https=) |
| IL (1) | IL209028A (https=) |
| MX (1) | MX2010011309A (https=) |
| NZ (1) | NZ587865A (https=) |
| UA (1) | UA102097C2 (https=) |
| WO (1) | WO2009133103A1 (https=) |
| ZA (1) | ZA201006353B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2424898A4 (en) * | 2009-04-30 | 2012-12-05 | Univ Mcgill | CONJUGATES OF GM-CSF AND INTERLEUKIN-21 AND USES THEREOF IN MODULATION OF IMMUNE RESPONSE AND TREATMENT OF CANCER |
| AU2012204574B2 (en) * | 2011-01-04 | 2017-05-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating age-related macular degeneration |
| CN103827143A (zh) | 2011-07-06 | 2014-05-28 | 莫弗系统股份公司 | 抗cd20抗体和抗gm-csf抗体的治疗性组合产品及其用途 |
| WO2013026059A1 (en) * | 2011-08-18 | 2013-02-21 | New York University | Inhibition of oncogenic kras-induced gm-csf production and function |
| WO2013090989A1 (en) | 2011-12-22 | 2013-06-27 | Csl Limited | Method of treating inflammatory bowel disease |
| WO2014068029A1 (en) * | 2012-10-31 | 2014-05-08 | Takeda Gmbh | Lyophilized formulation comprising gm-csf neutralizing compound |
| AR093297A1 (es) | 2012-10-31 | 2015-05-27 | Amgen Res Munich Gmbh | Formulacion liquida que comprende un compuesto neutralizante de gm-csf |
| US10745475B2 (en) | 2013-08-30 | 2020-08-18 | Takeda Gmbh | Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics |
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| US11655293B2 (en) | 2018-02-22 | 2023-05-23 | Universitat Zurich | Ligands to GM-CSF or GM-CSF-receptor for use in leukemia in a patient having undergone allo-HCT |
| CN111690063A (zh) * | 2020-05-25 | 2020-09-22 | 北京大学 | 一种抗gm-csf纳米抗体及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309636B1 (en) * | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| WO2004042009A2 (en) * | 2002-10-30 | 2004-05-21 | Genentech, Inc. | Inhibition of il-17 production |
| GB0417487D0 (en) * | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| US20060177436A1 (en) * | 2004-12-16 | 2006-08-10 | Genentech, Inc. | Methods for Treating Autoimmune Disorders |
| BRPI0608281B8 (pt) * | 2005-04-18 | 2021-05-25 | Amgen Res Munich Gmbh | anticorpo monoclonal humano ou seu fragmento, seu uso no tratamento de doenças inflamatórias, bem como composição farmacêutica que o compreende |
| US7741450B2 (en) * | 2006-02-08 | 2010-06-22 | Morphotek Inc. | Antibodies to GM-CSF |
-
2009
- 2009-04-28 CA CA2717987A patent/CA2717987C/en not_active Expired - Fee Related
- 2009-04-28 CN CN2009801155219A patent/CN102014958A/zh active Pending
- 2009-04-28 NZ NZ587865A patent/NZ587865A/en not_active IP Right Cessation
- 2009-04-28 EA EA201001496A patent/EA024654B1/ru not_active IP Right Cessation
- 2009-04-28 BR BRPI0911469A patent/BRPI0911469A8/pt not_active Application Discontinuation
- 2009-04-28 ES ES09738147.9T patent/ES2557494T3/es active Active
- 2009-04-28 JP JP2011506688A patent/JP5771140B2/ja active Active
- 2009-04-28 KR KR1020167026990A patent/KR20160117643A/ko not_active Ceased
- 2009-04-28 AU AU2009242088A patent/AU2009242088B2/en not_active Ceased
- 2009-04-28 US US12/990,006 patent/US9353180B2/en active Active
- 2009-04-28 EP EP09738147.9A patent/EP2279001B1/en active Active
- 2009-04-28 CN CN201410267649.XA patent/CN104338136A/zh active Pending
- 2009-04-28 MX MX2010011309A patent/MX2010011309A/es active IP Right Grant
- 2009-04-28 KR KR1020107026144A patent/KR101681331B1/ko not_active Expired - Fee Related
- 2009-04-28 UA UAA201014289A patent/UA102097C2/ru unknown
- 2009-04-28 WO PCT/EP2009/055129 patent/WO2009133103A1/en not_active Ceased
-
2010
- 2010-09-06 ZA ZA2010/06353A patent/ZA201006353B/en unknown
- 2010-10-31 IL IL209028A patent/IL209028A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011518857A5 (https=) | ||
| CN104774266B (zh) | 白介素-13结合蛋白 | |
| JP5836130B2 (ja) | ヒトｉｌ−１３に結合特異性を有する抗体分子 | |
| RU2007138341A (ru) | Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека | |
| TW201031421A (en) | IL-1 binding proteins | |
| JP2007514419A5 (https=) | ||
| JP2009539349A5 (https=) | ||
| JP2023505492A5 (https=) | ||
| TW201124427A (en) | IL-1 binding proteins | |
| JP2008542321A5 (https=) | ||
| HK1256740B (en) | Interleukin -13 binding proteins | |
| HK1128495B (en) | Interleukin -13 binding proteins | |
| HK1128495A (en) | Interleukin -13 binding proteins |